# Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine

> **NCT04173832** · NA · UNKNOWN · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 100 (estimated)

## Conditions studied

- L-DOPA-Induced Dyskinesia

## Interventions

- **DRUG:** Tianqi Pingchan Granule Combined With Amantadine
- **DRUG:** Placebo Combined With Amantadine

## Key facts

- **NCT ID:** NCT04173832
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-12-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04173832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04173832, "Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04173832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*